Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants

E Meijer, GJ Boland, LF Verdonck - Clinical microbiology reviews, 2003 - Am Soc Microbiol
The main risk factors for cytomegalovirus (CMV) disease in recipients of allogeneic stem cell
transplants (SCT) are recipient CMV seropositivity and acute graft-versus-host disease …

Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation

XY Meng, HX Fu, XL Zhu, JZ Wang, X Liu, CH Yan… - Annals of …, 2020 - Springer
Cytomegalovirus (CMV) can cause end-organ diseases including pneumonia,
gastroenteritis, retinitis, and encephalitis in hematopoietic stem cell transplantation …

Organ Transplant Recipients

J Sassine, S Shah - Global Virology IV: Viral Disease Diagnosis and … - books.google.com
Cytomegalovirus is a common opportunistic infection in solid organ and hematopoietic cell
transplant patients. The symptoms of patients with this infection can vary and target many …

Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus …

C Girmenia, T Lazzarotto, F Bonifazi… - Clinical …, 2019 - Wiley Online Library
Cytomegalovirus (CMV) remains a major cause of morbidity and mortality in allogeneic
hematopoietic stem cell transplantation (allo‐HSCT) and solid organ transplantation (SOT) …

[HTML][HTML] Cytomegalovirus infection in the bone marrow transplant patient

V Bhat, A Joshi, R Sarode, P Chavan - World journal of …, 2015 - ncbi.nlm.nih.gov
Cytomegalovirus (CMV) infection is an important contributor to the morbidity and mortality
associated with bone marrow transplantation (BMT). Infection may lead to CMV disease …

Acceleration of allograft failure by cytomegalovirus

DN Streblow, SL Orloff, JA Nelson - Current opinion in immunology, 2007 - Elsevier
A number of human herpesviruses are important opportunistic pathogens that have been
associated with increased morbidity and mortality in transplant recipients including human …

[HTML][HTML] UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.: A …

JL Piñana, E Giménez, L Vázquez, MÁ Marcos… - … Journal of Hematology …, 2024 - mjhid.org
Background: Cytomegalovirus (CMV) infection is a common complication following
allogeneic hematopoietic stem cell transplantation (allo-HSCT) and in patients receiving …

Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients

DR Snydman, G Torres-Madriz… - Clinical Infectious …, 2008 - academic.oup.com
Cytomegalovirus (CMV) infection is an important complication of solid-organ transplantation.
The availability of potent antiviral therapies has decreased the incidence of CMV disease …

Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients

G Torres-Madriz, HW Boucher - Clinical infectious diseases, 2008 - JSTOR
Cytomegalovirus (CMV) infection is an important complication of solid-organ transplantation.
The availability of potent antiviral therapies has decreased the incidence of CMV disease …

Betaherpesvirus complications and management during hematopoietic stem cell transplantation

T Yoshikawa - Human Herpesviruses, 2018 - Springer
Two of the four betaherpesviruses, Cytomegalovirus (CMV) and human herpesvirus 6B
(HHV-6B), play an important role in opportunistic infections in hematopoietic stem cell …